SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-036510
Filing Date
2023-06-12
Accepted
2023-06-12 20:17:24
Documents
1
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4289
  Complete submission text file 0001209191-23-036510.txt   5695
Mailing Address C/O MYOKARDIA, INC. 333 ALLERTON AVE SOUTH SAN FRANCISCO CA 94080
Business Address
Lee June (Reporting) CIK: 0001696493 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40656 | Film No.: 231009984

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Issuer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences